+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding



Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding



Journal of Experimental Medicine 172(4): 1101-1114



The expression of the 70-kD beta subunit of the interleukin 2 receptor (IL-2R) has been examined on peripheral blood lymphocytes (PBL) obtained from patients receiving systemic infusions of IL-2. Using monoclonal antibodies directed against p70, flow cytometric analyses revealed a greater than threefold increase in expression of the IL-2R beta chain on CD56+ natural killer (NK) cells from post-IL-2 therapy PBL relative to pre-therapy cells. The level of p70 expression on the post-therapy cells was three- to fourfold greater (based on fluorescence intensity) than the level of p70 expression on YT cells, an NK-like cell line that expresses approximately 12,000 intermediate affinity IL-2 binding sites/cell. Despite the high level of p70 expression, in 125I-IL-2 binding assays only 790-1,290 intermediate affinity IL-2 binding sites/cell were detected on post-therapy cells from six patients. These data represent the first report of increased p70 expression after in vivo IL-2 administration and suggest a requirement for at least one additional subunit for the formation of functional intermediate affinity IL-2Rs. Furthermore, the presence on the surface of post-therapy NK cells of excess p70 that does not bind IL-2 with intermediate affinity implies that the formation of intermediate affinity IL-2Rs is not solely determined by the level of p70 expression, and that the response of NK cells to IL-2 might be regulated by altering the expression of p70 or some other IL-2R subunit.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040407793

Download citation: RISBibTeXText

PMID: 1698909


Related references

Increased expression of the interleukin 2 (Il-2) receptor beta chain (p70) on Cd56+ natural killer cells after in vivo Il-2 therapy: p70 expression does not alone predict the level of intermediate affinity Il- 2 binding. Journal of Experimental Medicine 172(4): 1101-1114, 1990

Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis. Multiple Sclerosis 17(12): 1441-1448, 2011

Characterization of the interleukin 2 receptors il 2r expressed on human natural killer cells activated in vivo by il 2 association of the p64 il 2r gamma chain with the il 2r beta chain in functional intermediate affinity il 2r. Journal of Experimental Medicine 176(2): 531-541, 1992

Characterization of the interleukin 2 receptors (Il-2R) expressed on human natural killer cells activated in vivo by Il-2: association of the p64 Il-2R gamma chain with the Il-2R beta chain in functional intermediate-affinity Il-2R. Journal of Experimental Medicine 176(2): 531-541, 1992

Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth. European Journal of Immunology 26(1): 201-206, 1996

Inhibition of lymphokine-activated killer cells by human pulmonary macrophages: discordance between up-regulation of the beta chain (p75) of the interleukin-2 receptor on CD56+ cells and limited response to interleukin-2. American Journal of Respiratory Cell and Molecular Biology 10(2): 184-191, 1994

Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. European Journal of Immunology 23(8): 1831-1838, 1993

Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma. Cellular Immunology 170(1): 71-77, 1996

Enhancement by stem cell factor of interleukin-2 (IL-2)-induced DNA synthesis in human decidual CD16- CD56bright natural killer cells mediated by increased expression of the IL-2 receptor alpha chain. Journal of Reproductive Immunology 40(1): 1-24, 1998

Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. Journal of Experimental Medicine 171(5): 1527-1533, 1990

Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor alpha chain. British Journal of Haematology 105(3): 711-719, 1999

Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets. International Immunology 2(6): 481-486, 1990

Constitutive expression of high affinity interleukin 2 receptors on human cd16 negative natural killer cells in vivo. Journal of Experimental Medicine 171(5): 1527-1534, 1990

Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25. Oncoimmunology 7(2): E1381813, 2018

Enhanced interleukin 2 receptor expression on in vivo activated mouse natural killer cells. Natural Immunity & Cell Growth Regulation 4(5): 275, 1985